300,000 euros to research the cure for diabetes. Will it be enough?

There is news that, at first glance, should fill us with hope... but that also invites us to reflect a little beyond the headline.

The DiabetesCERO Foundation has announced the donation of 300,000 euros to promote four research projects focused on the cure for type 1 diabetes. On paper, it sounds good: support for new immunotherapies, stem cell research, innovative studies... all focused on moving towards something that we all want.

But to be honest... to what extent is this enough?

When we talk about biomedical research, we are talking about complex, long and extremely expensive processes.Clinical trials, development of therapies, validation of results… all of this requires millions, not hundreds of thousands.And this is where many of us may feel a certain bittersweet feeling.

Because of course it is positive that resources are allocated.Of course every euro adds up.But it also gives the impression that, sometimes, these types of initiatives remain more in the gesture than in the real impact.

And it is inevitable to ask: are we really moving towards a cure... or are we maintaining a system that needs to continue functioning, financing and justifying itself year after year?

This is not a criticism of the researchers, far from it.They are probably the ones who suffer the most from this lack of structural resources.It is rather a reflection on the model itself: small dispersed contributions, fragmented projects... compared to the real magnitude of the problem.

Meanwhile, people with type 1 diabetes are still here, day by day, managing a disease that gives no respite.And that means that any news about “progress towards a cure” is received with enthusiasm… but also with caution.

Perhaps the conversation we should have as a community is different: how we ensure that research has a truly transformative impact.How do we move from small initiatives to solid, sustained and coordinated strategies that truly accelerate change.

Because in the end, this is not about headlines.It's about lives.

What do you think?

Do you think that these types of initiatives really make a difference or do they also raise doubts about their real impact?

I read you.

For me personally, the context is given by the global research budget destined to search for a definitive cure and the net business volume derived from Type 1 Diabetes...Since 1997, the year I debuted, approximately $7.1 billion has been allocated to research from public funds and charities and foundations.

By 2026 alone, the turnover of Type 1 Diabetes will be about 60 billion dollars.

If the dream business model in pharma is the chronicification of diseases, the fact that there are serious intentions to end Diabetes is an idea that is difficult for me to digest...

I personally have no hope of seeing a cure.I hope I'm wrong...

I leave a table with estimated income by company, only in the Diabetes branch:

Hello @fer,

Unfortunately, with 300,000 euros I believe that little can be done, and even less so if it is spread over several projects.I understand that there are high costs for equipment, supplies, salaries of scientists, ... and with this amount it will barely be possible to cover a few months of research for each project, although it will always be better than nothing.

However, I consider that the initiative of these foundations and associations such as DiabetesCero and Aredi are truly admirable since they are made up of diabetics, fathers and mothers of children with diabetes, and who collaborate altruistically to collect funds and then be able to help finance these research projects.

I assume that the money is obtained mainly from membership fees, events, and non-refundable donations.I am afraid that the contributions from the public sector must be very small, so in the end the funds collected are very limited.

When possible I try to go to these types of events to collaborate, since a part of the entry will end up being allocated to research.It's just a drop, but every one counts.In case anyone is interested and is close by, Aredi has organized a walk for diabetes on May 10 in Viladecans (viladecans hike).

The large pharmaceutical companies with products for diabetes (Novo Nordisk, Elli Lilly, Sanofi,...) are unlikely to invest in a cure for diabetes since it would be throwing stones at their own roof.Companies are businesses and their objective is to maximize the benefit for the shareholder, which is why their line of research is aimed at treating the disease, working to obtain the best product that allows them to attract the greatest number of patients.Curing the disease is not profitable.